What is the Impact Factor of Clinical and Applied Thrombosis-Hemostasis?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical and Applied Thrombosis-Hemostasis is 2.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Clinical and Applied Thrombosis-Hemostasis indexed in Web of Science or Scopus?

Yes, Clinical and Applied Thrombosis-Hemostasis is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.671 (Q2) and an H-index of 66.

Who publishes Clinical and Applied Thrombosis-Hemostasis and what is the Article Processing Charge (APC)?

Clinical and Applied Thrombosis-Hemostasis is published by SAGE Publications Inc.. The estimated Article Processing Charge (APC) is approximately $3,096 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical and Applied Thrombosis-Hemostasis?

The official ISO-4 abbreviation of Clinical and Applied Thrombosis-Hemostasis is "CLIN APPL THROMB-HEM" with common acronym "cath". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #8,678Hybrid

Clinical and Applied Thrombosis-Hemostasis

Acronym:cath

•

Abbreviation (ISO):CLIN APPL THROMB-HEM

•

Identifier (ISSN):1076-0296(Print)/1938-2723(Online)

•

Publisher:SAGE Publications Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical and Applied Thrombosis-Hemostasis

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q2

0.671

#8,678

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

66 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate4.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

169articles/year

99.78% Gold OA•86.39% Original Research

Aims & Scope

CATH is a peer-reviewed bi-monthly journal that addresses the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. CATH covers clinical trials, studies on etiology, pathophysiology, diagnosis and treatment of thrombohemorrhagic disorders.

Topics Covered (Recognized by AI)

Medicine97.1%Internal medicine94%Biology80.5%Surgery72.2%Psychology71.1%Psychiatry69.9%Chemistry52%Biochemistry49.1%Immunology47.3%Pathology44.5%Genetics43.8%Cardiology42.6%Thrombosis35.9%Platelet32%Gastroenterology28.2%Mathematics25%Endocrinology24.9%Physics23.9%Statistics20.7%

Primary Research Areas

Medicine Peripheral Vascular Disease

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank61/103

IndexSCIE

JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Rank57/100

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank58/103

IndexSCIE

JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Rank61/100

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	61/103	Q3
PERIPHERAL VASCULAR DISEASE	JCRSCIE	57/100	Q3
HEMATOLOGY	JCISCIE	58/103	Q3
PERIPHERAL VASCULAR DISEASE	JCISCIE	61/100	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year163

Total Citations29

2025

IF2

Articles / Year154

Total Citations202

2024

IF2.3

Articles / Year139

Total Citations526

2023

IF2.9

Articles / Year167

Total Citations1,198

2022

IF3.512

Articles / Year182

Total Citations1,876

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	163	29
2025	2	154	202
2024	2.3	139	526
2023	2.9	167	1,198
2022	3.512	182	1,876
2021	2.389	187	2,817
2020	1.374	168	3,230
2019	1.846	116	3,050
2018	1.852	118	2,113
2017	—	110	2,126
2016	—	130	2,810
2015	—	109	2,436

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,678Scopus Q2SCImago Profile

Scopus Coverage:1995-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.671

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.12

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,096 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,109

3-Year Documents482

Citable Documents463

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ2

Medicine (miscellaneous)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区HEMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical and Applied Thrombosis-Hemostasis (acronym: cath, abbr: CLIN APPL THROMB-HEM, ISSN: 1076-0296) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in United States since 1995. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.671 (Q2), an H-index of 66.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 169 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,096 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.